These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11853927)

  • 1. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy.
    Yang C; Zhang Y; Cai P; Yuan S; Ma Q; Song Y; Wei H; Wu Z; Wu Z; Qi X
    J Drug Target; 2020 Jan; 28(1):102-110. PubMed ID: 31100991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
    McConville JT; Ross AC; Florence AJ; Stevens HN
    Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
    Mughal MA; Iqbal Z; Neau SH
    AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
    Yan G; Li H; Zhang R; Ding D
    Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ; Ryu SG; Cui JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and in vitro release of tetramethylpyrazine phosphate pulsincap capsule controlled by an erodible plug].
    Wu F; Zhang ZR; He WL; Zhang Y
    Yao Xue Xue Bao; 2002 Sep; 37(9):733-8. PubMed ID: 12567902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP; Wang MY; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
    Cox PJ; Khan KA; Munday DL; Sujja-areevath J
    Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of pH-dependent gradient-release pellets for TCM.
    Tang X; Tian X; Ci L
    Drug Dev Ind Pharm; 2004; 30(10):1079-87. PubMed ID: 15595574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
    Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
    Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.